🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Aminopyrimidine derivatives as protein kinases inhibitors. Molecular design, synthesis, and biologic activity


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The review compiles the strategies and methods of development of aminopyrimidine derivatives as targeted antitumor pharmaceuticals. The advances in organic and heterocyclic chemistry are considered in the targeted synthesis of aminopyrimidine derivatives whose series contains the most demanded and efficient antitrumor pharmaceuticals. The problems of preparation of compounds with multikinase activity profile and the construction of chimeric molecules are discussed.

About the authors

E. V. Koroleva

Institute of New Materials Chemistry

Author for correspondence.
Email: evk@ichnm.basnet.by
Belarus, ul. F. Skoriny 36, Minsk, 220141

Zh. I. Ignatovich

Institute of New Materials Chemistry

Email: evk@ichnm.basnet.by
Belarus, ul. F. Skoriny 36, Minsk, 220141

Yu. V. Sinyutich

Institute of New Materials Chemistry

Email: evk@ichnm.basnet.by
Belarus, ul. F. Skoriny 36, Minsk, 220141

K. N. Gusak

Institute of New Materials Chemistry

Email: evk@ichnm.basnet.by
Belarus, ul. F. Skoriny 36, Minsk, 220141

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Ltd.